---
title: "CSPC Pharmaceutical Launches 2026 Share Award Scheme as 2018 Plan Nears Limit"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/280484776.md"
description: "CSPC Pharmaceutical Launches 2026 Share Award Scheme as 2018 Plan Nears Limit"
datetime: "2026-03-25T13:43:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280484776.md)
  - [en](https://longbridge.com/en/news/280484776.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280484776.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/280484776.md) | [English](https://longbridge.com/en/news/280484776.md)


# CSPC Pharmaceutical Launches 2026 Share Award Scheme as 2018 Plan Nears Limit

CSPC Pharmaceutical Launches 2026 Share Award Scheme as 2018 Plan Nears Limit

### 相關股票

- [E Fund CSI Biotechnology Theme ETF (159837.CN)](https://longbridge.com/zh-HK/quote/159837.CN.md)
- [Fullgoal Hang Seng SCHK Innovative Drug & Healthcare ETF (159506.CN)](https://longbridge.com/zh-HK/quote/159506.CN.md)
- [GF CSI HK Innovative Drugs Industry ETF(QDII) (513120.CN)](https://longbridge.com/zh-HK/quote/513120.CN.md)
- [China Universal CNI HK Connect Innovative Drugs Industry ETF (159570.CN)](https://longbridge.com/zh-HK/quote/159570.CN.md)
- [Huatai-PB Hang Seng Innovative Drugs Industry ETF(QDII) (520500.CN)](https://longbridge.com/zh-HK/quote/520500.CN.md)
- [Hwabao WP Hang Seng SCHK Innovative Drug Select ETF (520880.CN)](https://longbridge.com/zh-HK/quote/520880.CN.md)
- [Penghua CSI HK Connect Health Care Composite ETF (513700.CN)](https://longbridge.com/zh-HK/quote/513700.CN.md)
- [China Merchants CSI Biotechnology Theme ETF (159849.CN)](https://longbridge.com/zh-HK/quote/159849.CN.md)
- [Guotai CSI Bio-medicine ETF (512290.CN)](https://longbridge.com/zh-HK/quote/512290.CN.md)
- [Minsheng Royal CSI Biotechnology Theme ETF (516930.CN)](https://longbridge.com/zh-HK/quote/516930.CN.md)
- [CSPC PHARMA (01093.HK)](https://longbridge.com/zh-HK/quote/01093.HK.md)
- [Hwabao WP CSI Pharmaceuticals ETF (562050.CN)](https://longbridge.com/zh-HK/quote/562050.CN.md)
- [Yinhua CSI Innovative Drugs Industry ETF (159992.CN)](https://longbridge.com/zh-HK/quote/159992.CN.md)
- [ChinaAMC Hang Seng Biotechnology Technology ETF(QDII) (159892.CN)](https://longbridge.com/zh-HK/quote/159892.CN.md)
- [ChinaAMC SSE STAR Biology and Medicine ETF (588130.CN)](https://longbridge.com/zh-HK/quote/588130.CN.md)
- [ChinaAMC CSI Biotechnology Theme ETF (516500.CN)](https://longbridge.com/zh-HK/quote/516500.CN.md)
- [Bosera Hang Seng Health Care ETF(QDII) (513060.CN)](https://longbridge.com/zh-HK/quote/513060.CN.md)
- [E Fund CSI 300 Health Care ETF (512010.CN)](https://longbridge.com/zh-HK/quote/512010.CN.md)
- [E Fund Hang Seng SCHK Innovative Drug ETF (159316.CN)](https://longbridge.com/zh-HK/quote/159316.CN.md)
- [Bosera Hang Seng SCHK Innovative Drug Select ETF (520690.CN)](https://longbridge.com/zh-HK/quote/520690.CN.md)
- [ChinaAMC SSE Health Care ETF Initiating Fund (510660.CN)](https://longbridge.com/zh-HK/quote/510660.CN.md)

## 相關資訊與研究

- [CSPC Pharma's Profit Falls 10% in 2025; Misses EPS, Revenue Estimates](https://longbridge.com/zh-HK/news/280415449.md)
- [CSPC Profit Slips but Dividend Rises as China Pharma Shifts to Innovation](https://longbridge.com/zh-HK/news/280418974.md)
- [Everest Medicines Publishes Audited 2025 Annual Results and Report](https://longbridge.com/zh-HK/news/280545353.md)
- [CSPC Wins China Approval for New Aprepitant Injection to Strengthen Antiemetic Portfolio](https://longbridge.com/zh-HK/news/280149874.md)
- [CSPC Pharma Gets China Nod for Obesity Drug Trial](https://longbridge.com/zh-HK/news/279944953.md)